AMLX
Price
$3.12
Change
+$0.18 (+6.12%)
Updated
Oct 4 closing price
33 days until earnings call
JAZZ
Price
$108.56
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
31 days until earnings call
Ad is loading...

AMLX vs JAZZ

Header iconAMLX vs JAZZ Comparison
Open Charts AMLX vs JAZZBanner chart's image
Amylyx Pharmaceuticals
Price$3.12
Change+$0.18 (+6.12%)
Volume$743.19K
CapitalizationN/A
Jazz Pharmaceuticals
Price$108.56
Change-$0.00 (-0.00%)
Volume$375.84K
CapitalizationN/A
View a ticker or compare two or three
AMLX vs JAZZ Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AMLX vs. JAZZ commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a StrongBuy and JAZZ is a StrongSell.

COMPARISON
Comparison
Oct 05, 2024
Stock price -- (AMLX: $2.94 vs. JAZZ: $109.38)
Brand notoriety: AMLX and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 68% vs. JAZZ: 45%
Market capitalization -- AMLX: $221.06M vs. JAZZ: $6.85B
AMLX [@Biotechnology] is valued at $221.06M. JAZZ’s [@Biotechnology] market capitalization is $6.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while JAZZ’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 5 bearish.
  • JAZZ’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а -8.13% price change this week, while JAZZ (@Biotechnology) price change was -1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was +3.11%, and the average quarterly price growth was -5.53%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 07, 2024.

JAZZ is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($6.85B) has a higher market cap than AMLX($221M). JAZZ has higher P/E ratio than AMLX: JAZZ (18.87) vs AMLX (2.69). JAZZ YTD gains are higher at: -11.073 vs. AMLX (-78.804). JAZZ has higher annual earnings (EBITDA): 1.22B vs. AMLX (-153.78M). JAZZ has more cash in the bank: 1.98B vs. AMLX (310M). AMLX has less debt than JAZZ: AMLX (3.14M) vs JAZZ (5.79B). JAZZ has higher revenues than AMLX: JAZZ (3.91B) vs AMLX (299M).
AMLXJAZZAMLX / JAZZ
Capitalization221M6.85B3%
EBITDA-153.78M1.22B-13%
Gain YTD-78.804-11.073712%
P/E Ratio2.6918.8714%
Revenue299M3.91B8%
Total Cash310M1.98B16%
Total Debt3.14M5.79B0%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
66
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXJAZZ
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 5 days ago
63%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 12 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMGAX23.340.41
+1.79%
Lord Abbett Growth Opportunities A
EMGRX10.480.15
+1.45%
Nuveen Small Cap Select A
FMILX59.580.55
+0.93%
Fidelity New Millennium
QCLVX35.200.30
+0.86%
Federated Hermes MDT Large Cap Value C
VKSDX10.480.03
+0.29%
Virtus KAR Small-Mid Cap Value A

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with ATRA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+6.12%
ATRA - AMLX
55%
Loosely correlated
+6.81%
IKNA - AMLX
54%
Loosely correlated
+1.80%
JAZZ - AMLX
43%
Loosely correlated
+0.76%
VNDA - AMLX
42%
Loosely correlated
+2.89%
NTLA - AMLX
41%
Loosely correlated
+1.93%
More